Lacticaseibacillus paracasei LPC-37®

Lacticaseibacillus paracasei LPC-37® is a highly researched, proprietary strain of lactic acid bacteria, renowned for its resilience and beneficial impact on human health. Sourced from robust and viable cultures, this gram-positive bacterium is a cornerstone of advanced probiotic formulations. Its intrinsic ability to withstand harsh gastric conditions, including low pH and bile salts, ensures a high survival rate through the gastrointestinal tract, allowing it to reach the intestines alive and exert its therapeutic effects. LPC-37® is characterized by its excellent adhesion properties to intestinal epithelial cells, a crucial factor for colonization and sustained beneficial activity within the gut microbiome. This particular strain is carefully cultivated to maintain its genetic stability and functional integrity, making it a reliable and efficacious ingredient for diverse supplement applications aimed at supporting overall well-being.

The primary health benefits of Lacticaseibacillus paracasei LPC-37® are predominantly centered around immune system modulation and digestive health. Scientific investigations have demonstrated its capacity to interact with the gut-associated lymphoid tissue (GALT), influencing the production of cytokines and chemokines, thereby supporting a balanced immune response. For instance, studies have shown that LPC-37® can promote the production of anti-inflammatory cytokines, contributing to the regulation of immune processes within the gut. Furthermore, this strain contributes to a healthy gut microbiota by competitively excluding pathogenic bacteria and producing beneficial metabolites such as short-chain fatty acids (SCFAs), which nourish colonocytes and support gut barrier integrity. This dual action of immune support and microbial balance underscores its value in promoting a robust internal defense system and optimal digestive function.

LPC-37® is highly versatile for incorporation into a wide array of supplement formulations, including capsules, powders, and functional foods. Its stability and viability make it an excellent choice for products requiring extended shelf life without significant loss of potency. Rigorous quality control measures, including identity verification and quantification of viable cells, are paramount to ensure the efficacy of LPC-37® in finished products. Clinical research, including randomized, placebo-controlled trials, has provided evidence supporting the strain's ability to positively influence immune markers and gastrointestinal comfort in human subjects. These studies reinforce the scientific basis for its use, highlighting its potential in applications ranging from daily digestive support to targeted immune enhancement. The specific strain designation, LPC-37®, ensures consistency and reproducibility of these demonstrated benefits, providing a reliable ingredient for formulators.